BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Czaja AJ. Immune inhibitory proteins and their pathogenic and therapeutic implications in autoimmunity and autoimmune hepatitis. Autoimmunity. 2019;52:144-160. [PMID: 31298041 DOI: 10.1080/08916934.2019.1641200] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Allouchery M, Beuvon C, Pérault-Pochat MC, Roblot P, Puyade M, Martin M. Safety of Immune Checkpoint Inhibitor Resumption after Interruption for Immune-Related Adverse Events, a Narrative Review. Cancers (Basel) 2022;14:955. [PMID: 35205703 DOI: 10.3390/cancers14040955] [Reference Citation Analysis]
2 Czaja AJ. Advancing Biologic Therapy for Refractory Autoimmune Hepatitis. Dig Dis Sci 2022. [PMID: 35147819 DOI: 10.1007/s10620-021-07378-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Vergani D, Terziroli Beretta-Piccoli B, Mieli-Vergani G. A reasoned approach to the treatment of autoimmune hepatitis. Dig Liver Dis 2021:S1590-8658(21)00307-8. [PMID: 34162505 DOI: 10.1016/j.dld.2021.05.033] [Reference Citation Analysis]
4 Youssry S, Hussein A, Moaaz M. The immunoregulatory axis (programmed death-1/programmed death ligand-1) on CD4+ T cells in lupus nephritis: association with vitamin D and chemokine C-X-C motif ligand 12. Microbiol Immunol 2021. [PMID: 34081342 DOI: 10.1111/1348-0421.12923] [Reference Citation Analysis]
5 Czaja AJ. Exploring the Pathogenic Role and Therapeutic Implications of Interleukin 2 in Autoimmune Hepatitis. Dig Dis Sci 2021;66:2493-512. [PMID: 32833154 DOI: 10.1007/s10620-020-06562-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
6 Mack CL, Adams D, Assis DN, Kerkar N, Manns MP, Mayo MJ, Vierling JM, Alsawas M, Murad MH, Czaja AJ. Diagnosis and Management of Autoimmune Hepatitis in Adults and Children: 2019 Practice Guidance and Guidelines From the American Association for the Study of Liver Diseases. Hepatology 2020;72:671-722. [PMID: 31863477 DOI: 10.1002/hep.31065] [Cited by in Crossref: 200] [Cited by in F6Publishing: 157] [Article Influence: 100.0] [Reference Citation Analysis]
7 Tan EK, Chao YX, West A, Chan LL, Poewe W, Jankovic J. Parkinson disease and the immune system - associations, mechanisms and therapeutics. Nat Rev Neurol 2020;16:303-18. [PMID: 32332985 DOI: 10.1038/s41582-020-0344-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 44] [Article Influence: 28.5] [Reference Citation Analysis]
8 Czaja AJ. Autoimmune Hepatitis: Surviving Crises of Doubt and Elimination. Clin Liver Dis (Hoboken) 2020;15:S72-81. [PMID: 32140216 DOI: 10.1002/cld.917] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Czaja AJ. Examining pathogenic concepts of autoimmune hepatitis for cues to future investigations and interventions. World J Gastroenterol 2019; 25(45): 6579-6606 [PMID: 31832000 DOI: 10.3748/wjg.v25.i45.6579] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]